Literature DB >> 18689308

[Envenomation and poisoning by venomous or poisonous animals. VII: arachnidism in the New World].

J P Chippaux1, A Alagón.   

Abstract

The incidence of scorpion stings and spider bites is high in Latin America. This is particularly true for Mexico, part of Amazonia, and southern and eastern Brazil. Centruroides and Tityus scorpion stings present a real danger for humans, especially children. Envenomation results in intense pain, neurological signs, and cardiorespiratory manifestations that can lead to death by acute pulmonary edema or heart failure. In the event of confirmed envenomation, antivenin must be administered as soon as possible in association with symptomatic treatment and, if necessary, cardiorespiratory resuscitation. Spider bites are a less frequent and severe. Envenomation by Loxosceles is extremely painful and necrotizing. Severe visceral complications can develop. An effective antivenim has recently become available for local and systemic envenomation. Envenomation by Latrodectus leads to neurological symptoms that can also be treated with antivenom. Envenomation by other spiders is less frequent and generally harmless.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18689308

Source DB:  PubMed          Journal:  Med Trop (Mars)        ISSN: 0025-682X


  3 in total

1.  Antivenom Evaluation by Electrophysiological Analysis.

Authors:  Rita Restano-Cassulini; Walter Garcia; Jorge F Paniagua-Solís; Lourival D Possani
Journal:  Toxins (Basel)       Date:  2017-02-23       Impact factor: 4.546

2.  [Situation of public laboratories manufacturing antivenoms in Latin AmericaA situação dos laboratórios públicos produtores de soros antivenenos na América Latina].

Authors:  Hui Wen Fan; Marco Antonio Natal Vigilato; Julio Cesar Augusto Pompei; José María Gutiérrez
Journal:  Rev Panam Salud Publica       Date:  2019-11-19

3.  Mortality caused by venomous animals in Venezuela (2000-2009): A new epidemiological pattern

Authors:  Leonardo De Sousa; Adolfo Borges; Enzo De Sousa-Insana; Aleikar Vásquez-Suárez
Journal:  Biomedica       Date:  2021-03-19       Impact factor: 0.935

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.